CAC
PRVL

Cowen and Company’s Prevail Therapeutics Inc. Common Stock PRVL Stock Holding History

Cowen and Company’s Portfolio PRVL Stock Details PRVL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-5,523
Closed -$127K – 558
2020
Q4 		$127K Buy
+5,523
New +$127K 0.01% 151